Bisoprolol Fumarate

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

52 API Suppliers, 14 USDMF, 18 CEP/COS, 8 JDMF, 12 EU WC, 4 KDMF, 10 NDC API, 39 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

3 Drugs in Development

3 Drugs in Development

INTERMEDIATES

12 Intermediates Suppliers

12 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

752 FDF Dossiers, 66 FDA Orange Book, 421 Europe, 22 Canada, 48 Australia, 63 South Africa, 132 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

4 SPI Pharma, 2 Seqens, 3 DKSH, 4 Faran Shimi Pharmaceutical, 2 Boai NKY Pharmaceuticals Ltd, 10 Gangwal Healthcare, 3 Nanjing Well Pharmaceutical, 1 ACG Worldwide, 5 Actylis, 1 Alcedo Pharmachem, 7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 16 BASF, 1 Clariant, 10 Corel Pharma Chem, 4 DFE Pharma, 1 Finar, 10 Gangwal Chemicals, 1 Huzhou Sunflower Pharmaceutical, 5 Ideal Cures Pvt Ltd, 3 Ingredion Pharma Solutions, 21 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 10 Microlex e.U, 1 Nanjing Bold Chemical, 2 Nomisma Healthcare, 2 Novo Excipients, 1 Pharmatrans-Sanaq, 4 Pluviaendo, 3 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 16 Roquette, 13 Seppic, 5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 9 Sigachi Industries, 2 The Dow Chemical Company, 3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

51 Fillers, Diluents & Binders, 47 Coating Systems & Additives, 30 Direct Compression, 26 Controlled & Modified Release, 20 Thickeners and Stabilizers, 19 Disintegrants & Superdisintegrants, 17 Granulation, 17 Solubilizers, 15 Film Formers & Plasticizers, 14 Lubricants & Glidants, 13 Topical, 13 Co-Processed Excipients, 10 Taste Masking, 8 Parenteral, 7 Emulsifying Agents, 6 Chewable & Orodispersible Aids, 5 API Stability Enhancers, 5 Rheology Modifiers, 5 Empty Capsules, 4 Vegetarian Capsules, 4 Surfactant & Foaming Agents, 4 Coloring Agents

DIGITAL CONTENT

1 DATA COMPILATION #PharmaFlow, 18 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 349 Finished Drug Prices, 3 Annual Reports

MARKET PLACE

28 APIs, 22 FDF Dossiers

REF. STANDARDS & IMPURITIES

3 EDQM, 1 USP, 15 Others

ANALYTICAL

4 BioAnalytical Methods

4 BioAnalytical Methods

$ Xls

Filters

Xls

USFDA APPLICATION NUMBER - 19982 / DOSAGE - TABLET;ORAL - 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
BISOPROLOL FUMARATE(UNII: UR59KN573L) (BISOPROLOL - UNII:Y41JS2NL6U)	BISOPROLOL FUMARATE	10mg \| 5mg

Inactive Ingredients

Ingredient Name	Teva Women's Health, Inc.
ANHYDROUS DIBASIC CALCIUM PHOSPHATE(L11K75P92J)
CELLULOSE, MICROCRYSTALLINE(OP1R32D61U)
CROSPOVIDONE (15 MPA.S AT 5%)(68401960MK)
FERRIC OXIDE RED(1K09F3G675)
FERRIC OXIDE YELLOW(EX438O2MRT)
HYPROMELLOSE 2910 (3 MPA.S)(0VUT3PMY82)
HYPROMELLOSE 2910 (6 MPA.S)(0WZ8WG20P6)
MAGNESIUM STEARATE(70097M6I30)
POLYETHYLENE GLYCOL 400(B697894SGQ)
POLYSORBATE 80(6OZP39ZG8H)
SILICON DIOXIDE(ETJ7Z6XBU4)
STARCH, CORN(O8232NY3SJ)
TITANIUM DIOXIDE(15FIX9V2JP)

Drug Product Composition: Bisoprolol Fumarate